A detailed history of Raymond James Trust N.A. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Raymond James Trust N.A. holds 322,234 shares of MRK stock, worth $38 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
322,234
Previous 317,969 1.34%
Holding current value
$38 Million
Previous $42 Million 4.92%
% of portfolio
0.94%
Previous 1.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$123.8 - $132.96 $528,007 - $567,074
4,265 Added 1.34%
322,234 $39.9 Million
Q1 2024

Apr 24, 2024

SELL
$113.24 - $131.95 $109,503 - $127,595
-967 Reduced 0.3%
317,969 $42 Million
Q4 2023

Jan 10, 2024

BUY
$100.18 - $109.02 $1.24 Million - $1.35 Million
12,367 Added 4.03%
318,936 $34.8 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $989,349 - $1.1 Million
9,610 Added 3.24%
306,569 $31.6 Million
Q2 2023

Aug 15, 2023

BUY
$108.61 - $118.38 $278,801 - $303,881
2,567 Added 0.87%
296,959 $34.3 Million
Q1 2023

May 03, 2023

BUY
$102.94 - $114.86 $23,676 - $26,417
230 Added 0.08%
294,392 $31.3 Million
Q4 2022

Feb 02, 2023

BUY
$87.44 - $112.11 $228,305 - $292,719
2,611 Added 0.9%
294,162 $32.6 Million
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $990,691 - $1.11 Million
11,720 Added 4.19%
291,551 $25.1 Million
Q2 2022

Jul 14, 2022

SELL
$83.49 - $94.64 $876,478 - $993,530
-10,498 Reduced 3.62%
279,831 $25.5 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $99,606 - $111,652
1,355 Added 0.47%
290,329 $23.8 Million
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $381,782 - $478,232
-5,282 Reduced 1.8%
288,974 $22.1 Million
Q3 2021

Oct 18, 2021

BUY
$71.68 - $78.83 $101,857 - $112,017
1,421 Added 0.49%
294,256 $22.1 Million
Q2 2021

Jul 20, 2021

SELL
$70.31 - $77.77 $461,936 - $510,948
-6,570 Reduced 2.19%
292,835 $22.8 Million
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $286,113 - $337,012
4,155 Added 1.41%
299,405 $23.1 Million
Q4 2020

Jan 13, 2021

BUY
$71.77 - $79.65 $84,545 - $93,827
1,178 Added 0.4%
295,250 $24.2 Million
Q3 2020

Oct 14, 2020

BUY
$73.18 - $82.95 $703,479 - $797,398
9,613 Added 3.38%
294,072 $24.4 Million
Q2 2020

Jul 16, 2020

BUY
$70.42 - $80.13 $593,288 - $675,095
8,425 Added 3.05%
284,459 $22 Million
Q1 2020

Apr 17, 2020

BUY
$63.36 - $87.82 $482,232 - $668,398
7,611 Added 2.84%
276,034 $21.2 Million
Q4 2019

Jan 14, 2020

BUY
$77.58 - $87.54 $665,403 - $750,830
8,577 Added 3.3%
268,423 $24.4 Million
Q3 2019

Oct 24, 2019

BUY
$76.08 - $82.93 $84,068 - $91,637
1,105 Added 0.43%
259,846 $21.9 Million
Q2 2019

Jul 15, 2019

BUY
$69.84 - $81.59 $275,309 - $321,627
3,942 Added 1.55%
258,741 $21.7 Million
Q1 2019

Apr 15, 2019

SELL
$69.58 - $79.36 $381,715 - $435,368
-5,486 Reduced 2.11%
254,799 $21.2 Million
Q4 2018

Jan 29, 2019

SELL
$65.24 - $75.71 $4.84 Million - $5.62 Million
-74,183 Reduced 22.18%
260,285 $19.9 Million
Q3 2018

Oct 16, 2018

SELL
$57.69 - $67.84 $47,825 - $56,239
-829 Reduced 0.25%
334,468 $23.7 Million
Q2 2018

Nov 26, 2018

BUY
$50.83 - $59.72 $279,565 - $328,460
5,500 Added 1.67%
335,297 $20.4 Million
Q2 2018

Jul 11, 2018

BUY
$50.83 - $59.72 $825,174 - $969,494
16,234 Added 5.18%
329,797 $20 Million
Q1 2018

Apr 05, 2018

SELL
$50.96 - $59.23 $162,358 - $188,706
-3,186 Reduced 1.01%
313,563 $17.1 Million
Q4 2017

Feb 02, 2018

SELL
$51.62 - $61.64 $61,324 - $73,228
-1,188 Reduced 0.37%
316,749 $17.8 Million
Q3 2017

Oct 24, 2017

SELL
$58.67 - $63.13 $710,728 - $764,756
-12,114 Reduced 3.67%
317,937 $20.4 Million
Q2 2017

Aug 10, 2017

BUY
N/A
330,051
330,051 $21.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.